Iradimed (IRMD) Assets (2013 - 2026)

Iradimed (IRMD) has 14 years of Assets data on file, last reported at $114.4 million in Q1 2026.

• On a quarterly basis, Assets rose 12.44% year-over-year to $114.4 million in Q1 2026; TTM through Mar 2026 was $114.4 million, a 12.44% increase from a year earlier, with the FY2025 full-year figure at $108.8 million, up 10.63% from the prior year.
• Assets for Q1 2026 stood at $114.4 million, up from $108.8 million in the prior quarter.
• Over the last five years, Assets for IRMD reached as high as $114.7 million in Q3 2025 and fell as low as $72.4 million in Q1 2022.
• Historically, Assets has averaged $92.1 million across 5 years, with a median of $89.9 million in 2024.
• Across the five-year window, Assets climbed 0.19% in 2022 and increased 21.72% in 2025, its largest moves.
• Year by year, Assets stood at $85.5 million in 2022, then advanced by 7.77% to $92.2 million in 2023, then climbed by 6.7% to $98.3 million in 2024, then grew by 10.63% to $108.8 million in 2025, then climbed by 5.16% to $114.4 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $114.4 million in Q1 2026, $108.8 million in Q4 2025, and $114.7 million in Q3 2025.